Article citationsMore>>

Gilhooley, M. (2011) Commercial Speech and Off-Label Drug Uses: What Role for Wide Acceptance, General Recognition and Research Incentives? American Journal of Law & Medicine, 37, 258-277.

has been cited by the following article:

• TITLE: The Ethics of Therapy Selection in Dermatology

  AUTHORS: Michael M. Wolz, Mark R. Pittelkow

  KEYWORDS: Ethical Issues, Moral Policies, Situational Ethics, Conflict of Interest, Beneficence

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.5 No.16, August 25, 2014

  ABSTRACT: Off-label use of medication is common in many areas of medicine and particularly in dermatology. Off-label use of medication, whether by prescription or use of samples, creates special ethical issues that include informed consent, patient autonomy and the fundamental adage “first, do no harm”. The choice of medication is also influenced by the patient and appropriate use ultimately depends on a thorough discussion of the risks and benefits as well as a mutually agreed treatment plan.